New registry aims to sharpen radiation treatment for rectal cancer

NCT ID NCT07501845

First seen Apr 08, 2026 · Last updated Jun 20, 2026 · Updated 12 times

Summary

This study is collecting information from up to 999 rectal cancer patients treated with a special radiation applicator called MAASTRO HDR. The goal is to learn how well the treatment works and what side effects occur, so doctors can improve future care. Participants will be followed for up to 10 years to track cancer control and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maastro

    RECRUITING

    Maastricht, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better understand how to use this radiation device to treat rectal cancer while sparing healthy tissue.

What could go wrong

This is an observational registry, not a treatment trial, so it won't directly test a new therapy. Results may take years and might not lead to immediate changes in care.

Conditions

The condition(s) this trial relates to.

rectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.